Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nucleosome assembly protein 1-like 4 pseudogene 2 (NAP1L4P2) is a processed pseudogene in the human genome related to the nucleosome assembly protein family, specifically the parental gene NAP1L4[3]. Processed pseudogenes are non-coding DNA sequences derived from mRNA reverse transcription and genomic insertion, typically lacking introns and protein-coding function. While once regarded as non-functional genomic relics, some processed pseudogenes like those similar to NAP1L4P2 can regulate parental or related gene expression through mechanisms such as acting as decoys or sponges for microRNAs, contributing to RNA stability regulation, or participating in ceRNA networks[1][2]. There is no evidence that NAP1L4P2 encodes a protein or functions as a conventional therapeutic target such as an enzyme, receptor, channel, or transporter. No small molecules, biologics, or diagnostic biomarkers are known to interact with this pseudogene, nor does it have known clinical safety implications. Its functional relevance is limited to potential regulatory roles at the RNA level, a property shared by several pseudogenes[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nucleosome assembly protein 1-like 4 pseudogene 2 (NAP1L4P2).